The JSE is poised for its best quarterly gain in about nine months, after a rollout of Covid-19 vaccines around the world fanned optimism of a quicker rebound in economic activity.

The JSE all share gained about 13% in the three months to March, though its performance earlier in March lost a bit of momentum...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now